S&P 500   4,276.10 (+0.05%)
DOW   33,889.26 (-0.27%)
QQQ   329.41 (+0.28%)
AAPL   174.21 (-0.19%)
MSFT   290.98 (-0.12%)
META   175.02 (+0.10%)
GOOGL   120.15 (+0.50%)
AMZN   142.35 (+0.18%)
TSLA   913.03 (+0.11%)
NVDA   187.40 (+2.21%)
NIO   19.89 (-0.95%)
BABA   90.73 (+1.07%)
AMD   100.46 (+2.23%)
MU   63.08 (+2.37%)
T   18.46 (+0.22%)
CGC   3.78 (-6.90%)
F   16.04 (+0.06%)
GE   79.26 (-0.83%)
DIS   122.46 (-0.28%)
AMC   19.96 (-6.55%)
PYPL   98.85 (-0.57%)
PFE   48.46 (-1.64%)
NFLX   245.07 (+1.63%)
S&P 500   4,276.10 (+0.05%)
DOW   33,889.26 (-0.27%)
QQQ   329.41 (+0.28%)
AAPL   174.21 (-0.19%)
MSFT   290.98 (-0.12%)
META   175.02 (+0.10%)
GOOGL   120.15 (+0.50%)
AMZN   142.35 (+0.18%)
TSLA   913.03 (+0.11%)
NVDA   187.40 (+2.21%)
NIO   19.89 (-0.95%)
BABA   90.73 (+1.07%)
AMD   100.46 (+2.23%)
MU   63.08 (+2.37%)
T   18.46 (+0.22%)
CGC   3.78 (-6.90%)
F   16.04 (+0.06%)
GE   79.26 (-0.83%)
DIS   122.46 (-0.28%)
AMC   19.96 (-6.55%)
PYPL   98.85 (-0.57%)
PFE   48.46 (-1.64%)
NFLX   245.07 (+1.63%)
S&P 500   4,276.10 (+0.05%)
DOW   33,889.26 (-0.27%)
QQQ   329.41 (+0.28%)
AAPL   174.21 (-0.19%)
MSFT   290.98 (-0.12%)
META   175.02 (+0.10%)
GOOGL   120.15 (+0.50%)
AMZN   142.35 (+0.18%)
TSLA   913.03 (+0.11%)
NVDA   187.40 (+2.21%)
NIO   19.89 (-0.95%)
BABA   90.73 (+1.07%)
AMD   100.46 (+2.23%)
MU   63.08 (+2.37%)
T   18.46 (+0.22%)
CGC   3.78 (-6.90%)
F   16.04 (+0.06%)
GE   79.26 (-0.83%)
DIS   122.46 (-0.28%)
AMC   19.96 (-6.55%)
PYPL   98.85 (-0.57%)
PFE   48.46 (-1.64%)
NFLX   245.07 (+1.63%)
S&P 500   4,276.10 (+0.05%)
DOW   33,889.26 (-0.27%)
QQQ   329.41 (+0.28%)
AAPL   174.21 (-0.19%)
MSFT   290.98 (-0.12%)
META   175.02 (+0.10%)
GOOGL   120.15 (+0.50%)
AMZN   142.35 (+0.18%)
TSLA   913.03 (+0.11%)
NVDA   187.40 (+2.21%)
NIO   19.89 (-0.95%)
BABA   90.73 (+1.07%)
AMD   100.46 (+2.23%)
MU   63.08 (+2.37%)
T   18.46 (+0.22%)
CGC   3.78 (-6.90%)
F   16.04 (+0.06%)
GE   79.26 (-0.83%)
DIS   122.46 (-0.28%)
AMC   19.96 (-6.55%)
PYPL   98.85 (-0.57%)
PFE   48.46 (-1.64%)
NFLX   245.07 (+1.63%)
OTCMKTS:MCUJF

Medicure - MCUJF Stock Forecast, Price & News

$0.83
0.00 (0.00%)
(As of 08/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.78
$0.83
50-Day Range
$0.73
$1.01
52-Week Range
$0.64
$1.10
Volume
4,000 shs
Average Volume
6,193 shs
Market Capitalization
$8.51 million
P/E Ratio
13.83
Dividend Yield
N/A
Price Target
N/A
MCUJF stock logo

About Medicure (OTCMKTS:MCUJF) Stock

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure. Further, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail pharmacies, as well as online. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

Receive MCUJF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.

MCUJF Stock News Headlines

Medicure Q3 2020 Results and Conference Call Dates
How Much Did Medicure's (CVE:MPH) CEO Pocket Last Year?
See More Headlines
Receive MCUJF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.

MCUJF Company Calendar

Last Earnings
5/30/2022
Today
8/18/2022
Next Earnings (Estimated)
8/25/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:MCUJF
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-580,000.00
Pretax Margin
3.55%

Debt

Sales & Book Value

Annual Sales
$17.17 million
Cash Flow
$0.19 per share
Book Value
$1.43 per share

Miscellaneous

Free Float
8,929,000
Market Cap
$8.51 million
Optionable
Not Optionable
Beta
0.83

Key Executives

  • Dr. Albert David Friesen Ph.D. (Age 75)
    Founder, CEO & Chairman of the board
    Comp: $232.67k
  • Dr. Neil Owens Ph.D.
    Pres & COO
  • Mr. Haaris Uddin B.Com.
    CPA, Chief Financial Officer
  • Dr. Reuben Saba Ph.D.
    VP of Scientific & Medical Affairs
  • Ms. Jamie Gowryluk
    VP of Commercial Operations













MCUJF Stock - Frequently Asked Questions

How have MCUJF shares performed in 2022?

Medicure's stock was trading at $0.73 at the beginning of 2022. Since then, MCUJF shares have increased by 13.7% and is now trading at $0.83.
View the best growth stocks for 2022 here
.

Are investors shorting Medicure?

Medicure saw a decline in short interest in July. As of July 31st, there was short interest totaling 300 shares, a decline of 57.1% from the July 15th total of 700 shares. Based on an average daily trading volume, of 6,500 shares, the short-interest ratio is currently 0.0 days.
View Medicure's Short Interest
.

When is Medicure's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 25th 2022.
View our MCUJF earnings forecast
.

How were Medicure's earnings last quarter?

Medicure Inc. (OTCMKTS:MCUJF) posted its earnings results on Monday, May, 30th. The company reported $0.04 EPS for the quarter. The company earned $4.51 million during the quarter. Medicure had a net margin of 3.40% and a trailing twelve-month return on equity of 4.28%.

What is Medicure's stock symbol?

Medicure trades on the OTCMKTS under the ticker symbol "MCUJF."

How do I buy shares of Medicure?

Shares of MCUJF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medicure's stock price today?

One share of MCUJF stock can currently be purchased for approximately $0.83.

How much money does Medicure make?

Medicure (OTCMKTS:MCUJF) has a market capitalization of $8.51 million and generates $17.17 million in revenue each year. The company earns $-580,000.00 in net income (profit) each year or $0.06 on an earnings per share basis.

How can I contact Medicure?

Medicure's mailing address is 2 - 1250 WAVERLEY STREET, WINNIPEG A2, R3T 6C6. The official website for the company is www.medicure.com. The company can be reached via phone at (204) 487-7412, via email at ir@medicure.com, or via fax at 204-488-9823.

This page (OTCMKTS:MCUJF) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.